References
- Bucchi L, Pizzato M, Rosso S, Ferretti S. New insights into the epidemiology of vulvar cancer: systematic literature review for an update of incidence and risk factors. Cancers 2022; 14: 389. doi: 10.3390/cancers14020389
- Wei S, Li L, Yi T, Su L, Gao Q, Wu L, et al. Epidemiologic characteristics and a prognostic nomogram for patients with vulvar cancer: results from the surveillance, epidemiology, and end results (SEER) program in the United States, 1975 to 2016. J Gynecol Oncol 2023; 34: e81. doi: 10.3802/jgo.2023.34.e81
- Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, et al. Vulvar cancer, version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2024; 22: 117-35. doi: 10.6004/jnccn.2024.0013
- Holleczek B, Sehouli J, Barinoff J. Vulvar cancer in Germany: increase in incidence and change in tumour biological characteristics from 1974 to 2013. Acta Oncologica 2018; 57: 324-30. doi: 10.1080/0284186X.2017.1360513
- Olawaiye AB, Cuello MA, Rogers LJ. Cancer of the vulva: 2021 update. Int J Gynaecol Obstet 2021; 155(Suppl 1): 7-18. doi:10.1002/ijgo.13881
- Tan A, Bieber AK, Stein JA, Pomeranz MK. Diagnosis and management of vulvar cancer: a review. J Am Acad Dermatol 2019; 81: 1387-96. doi: 10.1016/j.jaad.2019.07.055
- Pedrão PG, Guimarães YM, Godoy LR, Possati-Resende JC, Bovo AC, Andrade CEMC, et al. Management of early-stage vulvar cancer. Cancers 2022; 14: 4184. doi: 10.3390/cancers14174184
- Oonk MHM, Planchamp F, Baldwin P, Mahner S, Mirza MR, Fischerová D, et al. European Society of Gynaecological Oncology guidelines for the management of patients with vulvar cancer-update 2023. Int J Gynecol Cancer 2023; 33: 1023-43. doi: 10.1136/ijgc-2023-004486
- Zach D, Åvall-Lundqvist E, Falconer H, Hellman K, Johansson H, Flöter Rådestad A. Patterns of recurrence and survival in vulvar cancer: a nationwide population-based study. Gynecol Oncol 2021; 161: 748-54. doi: 10.1016/j.ygyno.2021.03.013
- Pleunis N, Pouwer AFW, Oonk MHM, van Doorn HC, Tjiong MY, van der Velden J, et al. Incidence of inguinofemoral lymph node metastases at the first local recurrence of vulvar cancer: a Dutch nationwide study. Br J Cancer 2023; 129: 956-64. doi: 10.1038/s41416-023-02373-0
- Te Grootenhuis NC, van der Zee AGJ, van Doorn HC, van der Velden J, Vergote I, Zanagnolo V, et al. Sentinel nodes in vulvar cancer: long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol 2016; 140: 8-14. doi: 10.1016/j.ygyno.2015.09.077
- Malandrone F, Bevilacqua F, Merola M, Gallio N, Ostacoli L, Carletto S, et al. The impact of vulvar cancer on psychosocial and sexual functioning: a literature review. Cancers 2021; 14: 63. doi: 10.3390/cancers14010063
- Vivod G, Bosnjak M, Kovacevic N, Sersa G, Merlo S, Cemazar M. Safety and feasibility of vulvar cancer treatment with electrochemotherapy. Cancers 2023; 15: 3079. doi:10.3390/cancers15123079
- Giannini A, D’Oria O, Chiofalo B, Bruno V, Baiocco E, Mancini E, et al. The giant steps in surgical downsizing toward a personalized treatment of vulvar cancer. J Obstet Gynaecol Res 2022; 48: 533-40. doi: 10.1111/jog.15103
- Merlo S. Modern treatment of vulvar cancer. Radiol Oncol 2020; 54: 371-76. doi: 10.2478/raon-2020-0053
- Vivod G, Omerzel M, Kovacevic N, Gasljevic G, Cilensek I, Sersa G, et al. Treatment of vulvar cancer recurrence with electrochemotherapy: a case-control study. Acta Oncol 2024; 63: 351-7. doi: 10.2340/1651-226X.2024.33241
- Mali B, Miklavcic D, Campana LG, Cemazar M, Sersa G, Snoj M, et al. Tumor size and effectiveness of electrochemotherapy. Radiol Oncol 2013; 47: 3241. doi: 10.2478/raon-2013-0002
- Campana LG, Miklavčič D, Bertino G, Marconato R, Valpione S, Imarisio I, et al. Electrochemotherapy of superficial tumors - current status: basic principles, operating procedures, shared indications, and emerging applications. Semin Oncol 2019; 46: 173-91. doi: 10.1053/j.seminoncol.2019.04.002
- Sersa G, Ursic K, Cemazar M, Heller R, Bosnjak M, Campana LG. Biological factors of the tumour response to electrochemotherapy: review of the evidence and a research roadmap. Eur J Surg Oncol 2021; 47: 1836-46. doi: 10.1016/j.ejso.2021.03.229
- Clover AJP, de Terlizzi F, Bertino G, Curatolo P, Odili J, Campana LG, et al. Electrochemotherapy in the treatment of cutaneous malignancy: outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019). Eur J Cancer 2020; 138: 30-40. doi: 10.1016/j.ejca.2020.06.020
- Merlo S, Vivod G, Bebar S, Bošnjak M, Čemažar M, Serša G, et al. Literature review and our experience with bleomycin-based electrochemotherapy for cutaneous vulvar metastases from endometrial cancer. Technol Cancer Res Treat 2021; 20: 15330338211010134. doi: 10.1177/15330338211010134
- Milicevic S, Cemazar M, Ivancic AK, Gasljevic G, Bosnjak M, Sersa G, et al. Electrochemotherapy of melanoma cutaneous metastases in organ transplant recipients: a systematic review of preclinical and clinical studies. Int J Mol Sci 2023; 24: 8335. doi: 10.3390/ijms24098335
- Rullo V, Castellaneta F, D’Antonio S, De Rosa A, Grieco MP, Fabrizio T. Electrochemotherapy in Kaposi’s sarcoma patients: from the gold standard strategy to locally advanced cutaneous and subcutaneous lesions. Cancers 2024; 16: 1295. doi: 10.3390/cancers16071295
- Djokic M, Cemazar M, Bosnjak M, Dezman R, Badovinac D, Miklavcic D, et al. A prospective phase ii study evaluating intraoperative electrochemotherapy of hepatocellular carcinoma. Cancers 2020; 12: E3778. doi: 10.3390/can-cers12123778
- Granata V, Fusco R, D’Alessio V, Simonetti I, Grassi F, Silvestro L, et al. Percutanous electrochemotherapy (ECT) in primary and secondary liver malignancies: a systematic review. Diagnostics 2023; 13: 209. doi:10.3390/diagnostics13020209
- Djokic M, Dezman R, Cemazar M, Stabuc M, Petric M, Smid LM, et al. Percutaneous image guided electrochemotherapy of hepatocellular carcinoma: technological advancement. Radiol Oncol 2020; 54: 347-52. doi: 10.2478/raon-2020-0038
- Schipilliti FM, Onorato M, Arrivi G, Panebianco M, Lerinò D, Milano A, et al. Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach. Radiol Oncol 2022; 56: 285-91. doi: 10.2478/raon-2022-0022
- Spallek H, Bischoff P, Zhou W, de Terlizzi F, Jakob F, Kovàcs A. Percutaneous electrochemotherapy in primary and secondary liver malignancies - local tumor control and impact on overall survival. Radiol Oncol 2022; 56: 102-10. doi: 10.2478/raon-2022-0003
- Cadossi R, Ronchetti M, Cadossi M. Locally enhanced chemotherapy by electroporation: clinical experiences and perspective of use of electrochemotherapy. Future Oncol 2014; 10: 877-890. doi: 10.2217/fon.13.235
- Perrone AM, Galuppi A, Pirovano C, Borghese G, Covarelli P, De Terlizzi F, et al. Palliative electrochemotherapy in vulvar carcinoma: preliminary results of the ELECHTRA (Electrochemotherapy Vulvar Cancer) multicenter study. Cancers 2019; 11: E657. doi: 10.3390/cancers11050657
- Tranoulis A, Georgiou D, Founta C, Mehra G, Sayasneh A, Nath R. Use of electrochemotherapy in women with vulvar cancer to improve quality-of-life in the palliative setting: a meta-analysis. Int J Gynecol Cancer 2020; 30: 107-14. doi: 10.1136/ijgc-2019-000868
- Corrado G, Cutillo G, Fragomeni SM, Bruno V, Tagliaferri L, Mancini E, et al. Palliative electrochemotherapy in primary or recurrent vulvar cancer. Int J Gynecol Cancer 2020; 30: 927-31. doi: 10.1136/ijgc-2019-001178
- Perrone AM, Corrado G, Coada CA, Garganese G, Fragomeni SM, Tagliaferri L, et al. Electrochemotherapy with intravenous bleomycin for heavily pretreated vulvar cancer patients. Int J Gynecol Cancer 2023; 33: 473-81. doi: 10.1136/ijgc-2022-004127
- Vivod G, Jesenko T, Gasljevic G, Kovacevic N, Bosnjak M, Sersa G, et al. Treatment of vulvar cancer recurrences with electrochemotherapy - a detailed analysis of possible causes for unsuccessful treatment. Radiol Oncol 2023; 57: 121-6. doi: 10.2478/raon-2023-0010
- Wills A, Obermair A. A review of complications associated with the surgical treatment of vulvar cancer. Gynecol Oncol 2013; 131: 467-79. doi: 10.1016/j.ygyno.2013.07.082
- Rahm C, Adok C, Dahm-Kähler P, Bohlin KS. Complications and risk factors in vulvar cancer surgery - a population-based study. Eur J Surg Oncol 2022; 48: 1400-6. doi: 10.1016/j.ejso.2022.02.006
- Roussin M, Lowe J, Hamilton A, Martin L. Sexual quality of life in young gynaecological cancer survivors: a qualitative study. Qual Life Res 2023; 32: 2107-15. doi: 10.1007/s11136-023-03386-1
- Chase DM, McCann LD, Treuth A, Cui H, Laniewski P, Jimenez NR, et al. Preoperative quality of life at time of gynecologic surgery: considerations for postoperative management. AJOG Glob Rep 2023; 3: 100275. doi: 10.1016/j.xagr.2023.100275
- Haber L, Allen A, Rune KT. Sexual quality of life following a cancer diagnosis: a qualitative study. Support Care Cancer 2023; 31: 125. doi:10.1007/s00520-022-07459-8
- Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001; 33: 337-43. doi: 10.3109/07853890109002087
- Fayers P, Bottomley A; EORTC Quality of Life Group, Quality of Life Unit. Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer 2002; 38(Suppl 4): S125-33. doi: 10.1016/s0959-8049(01)00448-8
- Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med 2001; 8: 1153-7. doi: 10.1111/j.1553-2712.2001.tb01132.x
- Prevolnik Rupel V, Srakar A, Rand K. Valuation of EQ-5D-3l health states in Slovenia: VAS based and TTO based value sets. Zdr Varst 2020; 59: 8-17. doi: 10.2478/sjph-2020-0002
- Froeding LP, Greimel E, Lanceley A, Oberguggenberger A, Schmalz C, Radisic VB, et al. Assessing patient-reported quality of life outcomes in vulva cancer patients: a systematic literature review. Int J Gynecol Cancer 2018; 28: 80817. doi: 10.1097/IGC.0000000000001211
- Gehl J, Sersa G, Matthiessen LW, Muir T, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol 2018; 57: 874-82. doi: 10.1080/0284186X.2018.1454602
- Jamsek C, Sersa G, Bosnjak M, Groselj A. Long term response of electrochemotherapy with reduced dose of bleomycin in elderly patients with head and neck non-melanoma skin cancer. Radiol Oncol 2020; 54: 79-85. doi: 10.2478/raon-2020-0009
- Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, DeConti RC, Gilbert RA, et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998; 83: 148-57. doi: 10.1002/(SICI)1097-0142(19980701)83:1<;148::AID-CNCR20>3.0.CO;2-W
- Valstad H, Eyjolfsdottir B, Wang Y, Kristensen GB, Skeie-Jensen T, Lindemann K. Pelvic exenteration for vulvar cancer: postoperative morbidity and oncologic outcome-a single center retrospective analysis. Eur J Surg Oncol 2023; 49: 106958. doi: 10.1016/j.ejso.2023.06.010
- Gil-Ibanez B, Davies-Oliveira J, Lopez G, Díaz-Feijoo B, Tejerizo-Garcia A, Sehouli J. Impact of gynecological cancers on health-related quality of life: historical context, measurement instruments, and current knowledge. Int J Gynecol Cancer 2023; 33: 1800-6. doi: 10.1136/ijgc-2023-004804